Search by Drug Name or NDC
NDC 58914-0170-14 Carafate 1 g/10mL Details
Carafate 1 g/10mL
Carafate is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is SUCRALFATE.
MedlinePlus Drug Summary
Sucralfate is used to treat and prevent the return of duodenal ulcers (ulcers located in first part of the small intestine). Treatment with other medications, such as antibiotics, may also be necessary to treat and prevent the return of ulcers caused by a certain type of bacteria (H. pylori) Sucralfate is in a class of medications called protectants. It sticks to damaged ulcer tissue and protects against acid and enzymes so healing can occur.
Related Packages: 58914-0170-14Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Sucralfate
Product Information
| NDC | 58914-0170 |
|---|---|
| Product ID | 58914-170_cac080ef-887e-4b68-beb8-b0f90b86f458 |
| Associated GPIs | 49300010001820 |
| GCN Sequence Number | 016133 |
| GCN Sequence Number Description | sucralfate ORAL SUSP 1 G/10 ML ORAL |
| HIC3 | D4E |
| HIC3 Description | ANTI-ULCER PREPARATIONS |
| GCN | 07651 |
| HICL Sequence Number | 001186 |
| HICL Sequence Number Description | SUCRALFATE |
| Brand/Generic | Brand |
| Proprietary Name | Carafate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sucralfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | g/10mL |
| Substance Name | SUCRALFATE |
| Labeler Name | Allergan, Inc. |
| Pharmaceutical Class | Aluminum Complex [EPC], Organometallic Compounds [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA019183 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 58914-0170-14 (58914017014)
| NDC Package Code | 58914-170-14 |
|---|---|
| Billing NDC | 58914017014 |
| Package | 414 mL in 1 BOTTLE (58914-170-14) |
| Marketing Start Date | 1993-12-16 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.60902 |
| Pricing Unit | ML |
| Effective Date | 2024-01-02 |
| NDC Description | CARAFATE 1 GM/10 ML SUSP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis